Home › Funds › Commodore Capital LP › CATX
Commodore Capital LP position in CATX
PERSPECTIVE THERAPEUTICS INC · Health Care
Commodore Capital LP reported holding 6,336,782 shares of CATX (PERSPECTIVE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$21.6M, representing 1.29% of its reported portfolio and ranking #19 among its reported holdings. Commodore Capital LP has disclosed CATX holdings in 5 of the last 10 reported quarters, going back to Q1 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Commodore Capital LP's CATX position evolved
Commodore Capital LP first disclosed a stake in CATX in Q1 2024 at 21,052,631 shares (US$25.1M). The position peaked in Q2 2024 at 4,657,345 shares, worth US$46.4M. Across 5 filings, Commodore Capital LP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 6,336,782 shares valued at US$21.6M. Notable position changes include a 78% trim in Q2 2024 (shares rose 34% over the following quarter), a 28% trim in Q3 2024 (shares fell 76% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 21.05M | $25.05M | New |
| Q2 2024 | 4.66M | $46.43M | Reduce |
| Q3 2024 | 3.35M | $44.72M | Reduce |
| Q1 2026 | 6.34M | $26.42M | New |
| Q2 2026 | 6.34M | $21.61M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CATX and 13F data
CATX (PERSPECTIVE THERAPEUTICS INC) is a Health Care company. 39 other funds we track also report a position in CATX — the largest reported positions include TCG Crossover Management, LLC (US$27.0M), Avidity Partners Management LP (US$21.5M), Affinity Asset Advisors, LLC (US$14.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CATX
- TCG Crossover Management, LLC 7.92M sh · $26.99M · Q2 2026
- Avidity Partners Management LP 6.30M sh · $21.48M · Q2 2026
- Affinity Asset Advisors, LLC 4.21M sh · $14.37M · Q2 2026
- Spruce Street Capital LP 3.69M sh · $12.60M · Q2 2026
- Nicholson Wealth Management Group, LLC 1.62M sh · $5.52M · Q2 2026
- Yu Fan 1.06M sh · $3.60M · Q2 2026
- Ally Bridge Group (NY) LLC 743.96K sh · $2.54M · Q2 2026
More on Commodore Capital LP
FAQ
How long has Commodore Capital LP held CATX?
Commodore Capital LP has disclosed CATX holdings in 5 of the last 10 reported quarters, going back to Q1 2024.
What is Commodore Capital LP's current position in CATX?
As of Q2 2026, Commodore Capital LP holds 6.34M shares of CATX (PERSPECTIVE THERAPEUTICS INC), valued at $21.61M, representing 1.29% of its reported portfolio and ranking #19.
Has Commodore Capital LP been buying or selling CATX?
In the latest 13F filing (Q2 2026), Commodore Capital LP held unchanged its position in CATX. The position peaked in Q2 2024 at 4.66M shares.
Which other funds hold CATX?
Other major institutional holders of CATX include TCG Crossover Management, LLC, Avidity Partners Management LP, Affinity Asset Advisors, LLC, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.